Giant Cell Glioblastoma
📧 Sign up to get email alerts when something new happens for Giant Cell Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery [Phase 1]
This clinical trial update reports on a Phase 1 study of the oncolytic herpes simplex virus HSV-1716 in children with refractory or recurren…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial update of erlotinib and sorafenib in progressive or recurrent glioblastoma multiforme; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]
Clinical trial update for Temsirolimus and Perifosine in recurrent or progressive malignant glioma (Phase 1/2) with completed status and pos…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Sunitinib in Treating Patients With Recurrent Malignant Gliomas [Phase 2]
Phase 2 trial evaluating sunitinib for adults with recurrent malignant gliomas has completed; results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
ClinicalTrials.gov indicates a completed Phase 1/2 study evaluating cilengitide with temozolomide and radiation for newly diagnosed glioblas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma [Phase 1, Phase 2]
Phase 1/2 trial evaluating RO4929097 in combination with Bevacizumab for progressive or recurrent malignant glioma was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme [Phase 1]
A Phase 1 study evaluating cilengitide in combination with sunitinib malate in adults with advanced solid tumors or glioblastoma multiforme …
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 1]
Phase 1 trial evaluating the combination of tipifarnib, temozolomide, and radiation therapy in newly diagnosed glioblastoma multiforme or gl…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
This Phase 1 trial update reports on the combination of tipifarnib, radiation therapy, and temozolomide in adults with newly diagnosed gliob…
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma [Phase 1]
A Phase 1 safety study evaluating cabozantinib (XL184) in combination with temozolomide and radiation for newly diagnosed glioblastoma has c…
-
CLINICAL_TRIALS withdrawal · 2014-06-02Clinical Trial Update: Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]
Phase 1 trial evaluating genetically modified stem cells with Irinotecan hydrochloride for recurrent high-grade gliomas has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and temozolomide with radiation therapy in adults with glioblastoma and rel…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating CCI-779 in patients with recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating gefitinib for newly diagnosed glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating vorinostat for progressive or recurrent glioblastoma multiforme has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating the combination of vorinostat and bortezomib in adults with progressive or recurrent glioblastoma multiforme; the…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma [Phase 2]
A Phase 2 clinical trial evaluating ritonavir and lopinavir for progressive or recurrent high-grade glioma was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 1]
This document reports the completion of a Phase 1 trial evaluating radiation therapy with gadolinium texaphyrin for supratentorial glioblast…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
Phase 1 study evaluating the combination of temsirolimus, temozolomide, and radiation therapy in newly diagnosed glioblastoma; the trial sta…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [Phase 1]
Phase 1 trial evaluating arsenic trioxide with radiation therapy in newly diagnosed malignant glioma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: RO4929097 in Treating Patients With Recurrent Invasive Gliomas [Phase 1]
Phase 1 trial update for RO4929097 in recurrent invasive gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating oxaliplatin for newly diagnosed glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant plus adjuvant fenretinide versus adjuvant fenretinide alone in patients undergoing surgery for…
-
CLINICAL_TRIALS research · 2013-01-16Clinical Trial Update: Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma [NA]
A terminated clinical trial evaluated the use of EF5 to measure oxygen levels in tumor cells of patients with newly diagnosed supratentorial…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]
This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refracto…